Pharmacy

Your Article Summary

See Latest Articles

Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection
Expert Opinion in Pharmacotherapy, 07/01/09

Iacobellis A et al. - Treatment is only recommended for a well-compensated liver cirrhosis, whereas antiviral therapy is commonly not implemented in cirrhotics with signs of liver decompensation, over the concern that the use of peginterferon and ribavirin might expose patients to severe treatment-related side effects. This review focuses on data available to support both efficacy and safety of antiviral therapy in both compensated and decompensated cirrhotic patients.

Today in Antimicrobials...keeping you current

Receive free subspecialty "5-minute updates" via email

Inotrope and vasopressor use in the emergency department
Emergency Medicine Australasia, 12/10/09

Bartonella bacilliformis, endemic pathogen of the Andean region, is intrinsically resistant to quinolones
International Journal of Infectious Diseases, 12/10/09

A microarray-based system for the simultaneous analysis of single nucleotide polymorphisms in human genes involved in the metabolism of anti-malarial drugs
Malaria Journal, 12/10/09

 See all of Antimicrobials

Today in Stomach/GI...keeping you current

Receive free subspecialty "5-minute updates" via email

A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism
Alimentary Pharmacology and Therapeutics, 12/10/09

Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection
Journal of Gastroenterology, 12/10/09

Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
Repligen, 12/10/09

 See all of Stomach/GI